The Lancet Psychiatry in conversation with

The Lancet Group
The Lancet Group
  • 0.0 (0)
  • Medicine

Editors from The Lancet Psychiatry, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. This podcast covers a broad range of topics, such as the latest advances in treatments for mental disorders, including drugs, psychotherapy and other interventions; physical health problems associated with mental illness and how to treat them; and social aspects of living with mental illness.

  1. Aug 17

    Psychosis in Low-income and Middle-income Countries

    People with psychosis experience poor physical as well as mental health and infringement of their human rights in several spheres. How is this being addressed through legal frameworks? Which interventions most effectively support recovery of people with psychosis? In this episode of In Conversation With, hosted by Joan Marsh (Editor-in-Chief, The Lancet Psychiatry), seven leading researchers from around the world discuss two in-depth reviews published in the journal that explore these questions with an emphasis on perspectives from low- and middle-income countries. Click here to read the full series: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(26)00156-2/fulltext https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(26)00033-7/fulltext

  2. Jun 17

    On Cannabis and Mental Health

    What does the science actually say about cannabis and mental health? In this episode of In Conversation With, hosted by Dustin Graham (Deputy Editor, The Lancet Psychiatry), three leading researchers unpack a landmark collection of papers on cannabis and mental health published in the journal. Dr. Jack Wilson (University of Sydney) breaks down a comprehensive meta-analysis of randomised controlled trials, revealing striking evidence gaps. Dr. Wayne Hall (University of Queensland) synthesises multiple forms of evidence, exploring cannabis's complex relationship with psychosis, anxiety, and depression. Professor Tom Freeman (University of Bath) zooms out to examine international cannabis policy, from decriminalisation to commercial legalisation, and what those shifts mean for psychiatric outcomes. Together, they tackle the tension between public demand, commercial interests, and a rapidly evolving evidence base — and what policymakers and clinicians urgently need to know. Read the full collection at thelancet.com

  3. Mar 19

    Tasdik Hasan on co-production of a Bangla mental health sign language bank

    A Health Policy piece in our April issue by Tasdik Hasan and co-authors titled:  Co-designing a Bangla Mental Health Sign Language Bank in Bangladesh https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00334-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  4. Feb 18

    Emily Holmes on an imagery competing task for intrusive trauma memories

    How can you stop traumatic flashbacks in just one session? Intrusive memories are so common after experiencing traumatic events and are one of the hallmark features of PTSD, but what if you could take away the power of those images without having to discuss them at length in therapy? In this episode, Emily Holmes talks about a new randomised controlled trial of an imagery-competing task, where participants are taught in just one guided session to recall a traumatic memory and then use mental rotation and playing Tetris, which had a strong effect on reducing intrusive memories and PTSD symptoms.  We talk about the neuroscience-informed development of this approach to trauma, and the importance of finding scalable and accessible approaches in psychological intervention research.  Click here to read the full article: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00397-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  5. Feb 12

    Mike Crawford on a brief intervention for personality disorder

    Can personality disorder treatments be reduced to just a few months? The evidence base for personality disorder treatments, like dialectical behavioural therapy (DBT) or mentalisation-based treatment (MBT), points towards treatments that last at least a year. Within the mental health field in general, though, in many countries there's a drive towards offering shorter treatments. But how short is too short, considering the needs of people with personality-related difficulties and the challenges in developing a therapeutic relationship? In this episode, Mike Crawford talks about a new study into a treatment of just 10 sessions using Structured Psychological Support, which draws on elements of DBT and MBT. We talk about the language used around personality disorder, how caution is now needed in reducing treatment duration, and about what to take forwards from this study for future treatment development. Click here to read the full article: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00372-4/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  6. Jan 21

    Ethelreda Nakimuli and Peter Jones on the COVID-19 pandemic and mental health

    How did the COVID-19 pandemic affect mental health?  Now that some years have passed since the pandemic's height, we can learn more from synthesising all the evidence about its shorter and longer term effects.  In this episode, Ethelreda Nakimuli and Peter Jones talk about two new papers that gather the past 5 years of work on the pandemic and mental health and policy approaches. They talk about the different effects of the pandemic on different groups' mental health, how mental health care was affected, and about what we can learn for future crises about different types of public health response to the pandemic. Click here to read the full articles: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00247-0 /fulltext https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00358-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  7. 12/10/2025

    Ilaria Costantini and Francesca Solmi on young people’s body dissatisfaction and mental health

    Body dissatisfaction has been rising among adolescents in recent years, and so have symptoms and diagnoses of mental disorders. To help us know what to do about increasing youth mental ill health, we need better understandings of what is driving it, but causal factors are hard to pin down.  In this episode, Ilaria Costantini and Francesca Solmi talk about their new study that uses a longitudinal twin study to disentangle the genetic and environmental factors in the associations between adolescent body dissatisfaction and later symptoms of eating disorder and depression. We think about why body dissatisfaction is such a key factor and talk about ways it could be tackled. Click here to read the full article: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00333-5/fulltext?dgcid=tlcom_podcast_acq-december25_lanpsy Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

  8. 11/11/2025

    Melissa DelBello on metformin for youth with bipolar disorder

    Weight gain is a typical side-effect of taking antipsychotics and can have a big impact on people. But for young people with bipolar disorder, metformin isn't commonly prescribed alongside an antipsychotic. In this episode, Melissa DelBello describes a huge randomised trial in the USA on metformin for young people with bipolar disorder taking antipsychotics, looking at its effects over a 2-year period. Click here to read the full article: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00273-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

See All (45)

About

Editors from The Lancet Psychiatry, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. This podcast covers a broad range of topics, such as the latest advances in treatments for mental disorders, including drugs, psychotherapy and other interventions; physical health problems associated with mental illness and how to treat them; and social aspects of living with mental illness.

Information

More From The Lancet Group

You Might Also Like